Hiroaki Nakagami

905 total citations
29 papers, 751 citations indexed

About

Hiroaki Nakagami is a scholar working on Pharmaceutical Science, Spectroscopy and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Hiroaki Nakagami has authored 29 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmaceutical Science, 6 papers in Spectroscopy and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Hiroaki Nakagami's work include Drug Solubulity and Delivery Systems (18 papers), Advanced Drug Delivery Systems (5 papers) and Pharmaceutical studies and practices (5 papers). Hiroaki Nakagami is often cited by papers focused on Drug Solubulity and Delivery Systems (18 papers), Advanced Drug Delivery Systems (5 papers) and Pharmaceutical studies and practices (5 papers). Hiroaki Nakagami collaborates with scholars based in Japan, United Kingdom and Germany. Hiroaki Nakagami's co-authors include Masazumi Kojima, Tatsuya Suzuki, Shuichi Ando, Etsuo Yonemochi, Tatsuya Suzuki, Katsuhide Terada, Susumu Uchiyama, Masanori Noda, Hirotaka Nishi and Kiichi Fukui and has published in prestigious journals such as Analytical Chemistry, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Hiroaki Nakagami

28 papers receiving 687 citations

Peers

Countries citing papers authored by Hiroaki Nakagami

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Nakagami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Nakagami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Nakagami more than expected).

Fields of papers citing papers by Hiroaki Nakagami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Nakagami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Nakagami. The network helps show where Hiroaki Nakagami may publish in the future.

Co-authorship network of co-authors of Hiroaki Nakagami

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Nakagami. A scholar is included among the top collaborators of Hiroaki Nakagami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Nakagami. Hiroaki Nakagami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bioequivalence Study of Ezetimibe Tablets After a Single Oral Dose of 10 mg in Healthy Japanese Subjects Under Fasting Conditions 2023 ·Clinical Pharmacology in Drug Development ·(unknown), (unknown), (unknown), Hiroaki Nakagami	2
2	Evaluation of Infrared-Reflection Absorption Spectroscopy Measurement and Locally Weighted Partial Least-Squares for Rapid Analysis of Residual Drug Substances in Cleaning Processes 2012 ·Analytical Chemistry ·Hiroshi Nakagawa, (unknown), Manabu Kano, Sanghong Kim, Shinji Hasebe, Tatsuya Suzuki, Hiroaki Nakagami	52
3	Improvement of low bioavailability of a novel factor Xa inhibitor through formulation of cationic additives in its oral dosage form 2011 ·International Journal of Pharmaceutics ·(unknown), (unknown), Hiroshi Kikuchi, Hiroaki Nakagami, Shinji Yamashita, Mitsuru Akashi, Shinji Sakuma	5
4	Colonoscopic method for estimating the colonic absorption of extended-release dosage forms in dogs 2010 ·European Journal of Pharmaceutics and Biopharmaceutics ·Shinichiro Tajiri, (unknown), Kazuhiro Yoshida, (unknown), (unknown), Tsutomu Konno, (unknown), Hiroaki Nakagami	6
5	Phase Separation of an IgG1 Antibody Solution under a Low Ionic Strength Condition 2010 ·Pharmaceutical Research ·Hirotaka Nishi, Makoto Miyajima, Hiroaki Nakagami, Masanori Noda, Susumu Uchiyama, Kiichi Fukui	101
6	Development of a method for nondestructive NIR transmittance spectroscopic analysis of acetaminophen and caffeine anhydrate in intact bilayer tablets 2010 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Tatsuya Suzuki, (unknown), Hiroaki Nakagami, (unknown), Etsuo Yonemochi, Katsuhide Terada	33
7	The Relationship between the Drug Concentration Profiles in Plasma and the Drug Doses in the Colon 2010 ·Chemical and Pharmaceutical Bulletin ·Shinichiro Tajiri, (unknown), Kazuhiro Yoshida, (unknown), Tsutomu Konno, (unknown), Hiroaki Nakagami	3
8	Prediction of recrystallization behavior of troglitazone/polyvinylpyrrolidone solid dispersion by solid-state NMR 2009 ·International Journal of Pharmaceutics ·(unknown), Tomoyuki Watanabe, (unknown), (unknown), Hiroaki Nakagami, Kenjirou Higashi, Kunikazu Moribe, Keiji Yamamoto	36
9	Dosage form design and in vitro/in vivo evaluation of cevimeline extended-release tablet formulations 2009 ·International Journal of Pharmaceutics ·Shinichiro Tajiri, (unknown), (unknown), Tsutomu Konno, Hiroaki Nakagami	12
10	Evaluation of solid dispersions on a molecular level by the Raman mapping technique 2008 ·International Journal of Pharmaceutics ·(unknown), Sunao Hasegawa, (unknown), (unknown), Hiroaki Nakagami, Etsuo Yonemochi, Katsuhide Terada	56
11	Development of a method for the determination of caffeine anhydrate in various designed intact tables by near-infrared spectroscopy: A comparison between reflectance and transmittance technique 2008 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Tatsuya Suzuki, (unknown), Akira Kusai, Hiroaki Nakagami, Etsuo Yonemochi, Katsuhide Terada	35
12	Effect of preparation method on properties of orally disintegrating tablets made by phase transition 2007 ·International Journal of Pharmaceutics ·(unknown), Masazumi Kojima, Shuichi Ando, Hiroaki Nakagami	25
13	Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols 2005 ·Journal of Controlled Release ·(unknown), Masazumi Kojima, Shuichi Ando, Hiroaki Nakagami	90
14	Development of controlled release matrix pellets by annealing with micronized water-insoluble or enteric polymers 2002 ·Journal of Controlled Release ·Masazumi Kojima, Hiroaki Nakagami	40
15	Effect of crystallinity of microcrystalline cellulose on the compactability and dissolution of tablets 1999 ·European Journal of Pharmaceutics and Biopharmaceutics ·Tatsuya Suzuki, Hiroaki Nakagami	71
16	Development of an abdominal magnetic resonance (MR) contrast agent formulation with Oral Magnetic Particles (OMP, Ferristene) 1998 ·Pharmaceutica Acta Helvetiae ·Manabu Matsumura, Hiroaki Nakagami, Chujun Chen, (unknown), Tsutomu Konno	1
17	Magnetic Resonance Imaging (MRI) Study of Swelling and Water Mobility in Micronized Low-Substituted Hydroxypropylcellulose Matri Tablets. 1998 ·Chemical and Pharmaceutical Bulletin ·Masazumi Kojima, Shuichi Ando, (unknown), (unknown), (unknown), Hiroaki Nakagami	31
18	Film Formation with Coating Systems of Aqueous Suspensions and Latex Dispersions of Ethylcellulose. 1994 ·Chemical and Pharmaceutical Bulletin ·(unknown), Hiroaki Nakagami	20
19	In vitro evaluation of micronized low-substituted hydroxypropylcellulose as an insoluble swellable matrix for sustained-release tablets. 1991 ·PubMed ·Hiroaki Nakagami, (unknown)	3
20	Effect of simultaneous administration of drugs on absorption and excretion. VI. Effect of protein binding on membrane permeability of sulfonamides. 1976 ·Chemical and Pharmaceutical Bulletin ·(unknown), Yorishige Imamura, Hiroaki Nakagami	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact